Gunnar F. Kaufmann - Net Worth and Insider Trading
Gunnar F. Kaufmann Net Worth
The estimated net worth of Gunnar F. Kaufmann is at least $2,494 dollars as of 2024-12-27. Gunnar F. Kaufmann is the Chief Scientific Officer of Oncternal Therapeutics Inc and owns about 4,736 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $2,494. Details can be seen in Gunnar F. Kaufmann's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gunnar F. Kaufmann has not made any transactions after 2023-06-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gunnar F. Kaufmann
Gunnar F. Kaufmann Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gunnar F. Kaufmann owns 1 companies in total, including Oncternal Therapeutics Inc (ONCT) .
Click here to see the complete history of Gunnar F. Kaufmann’s form 4 insider trades.
Insider Ownership Summary of Gunnar F. Kaufmann
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2023-06-14 | Chief Scientific Officer |
Gunnar F. Kaufmann Latest Holdings Summary
Gunnar F. Kaufmann currently owns a total of 1 stock. Gunnar F. Kaufmann owns 4,736 shares of Oncternal Therapeutics Inc (ONCT) as of June 14, 2023, with a value of $2,494.
Latest Holdings of Gunnar F. Kaufmann
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2023-06-14 | 4,736 | 0.53 | 2,494 |
Holding Weightings of Gunnar F. Kaufmann
Gunnar F. Kaufmann Form 4 Trading Tracker
According to the SEC Form 4 filings, Gunnar F. Kaufmann has made a total of 1 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Oncternal Therapeutics Inc is the acquisition of 1,400 shares on June 14, 2023, which cost Gunnar F. Kaufmann around $9,800.
Insider Trading History of Gunnar F. Kaufmann
- 1
Gunnar F. Kaufmann Trading Performance
GuruFocus tracks the stock performance after each of Gunnar F. Kaufmann's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gunnar F. Kaufmann is -6.26%. GuruFocus also compares Gunnar F. Kaufmann's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gunnar F. Kaufmann within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gunnar F. Kaufmann's insider trading performs compared to the benchmark.
Performance of Gunnar F. Kaufmann
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 30.94 | | | | | |
| Relative Return to S&P 500(%) | 27.9 | | | | | |
Gunnar F. Kaufmann Ownership Network
Gunnar F. Kaufmann Owned Company Details
What does Oncternal Therapeutics Inc do?
Who are the key executives at Oncternal Therapeutics Inc?
Gunnar F. Kaufmann is the Chief Scientific Officer of Oncternal Therapeutics Inc. Other key executives at Oncternal Therapeutics Inc include director & Executive Chairman Robert James Wills , Chief Medical Officer Salim Yazji , and director & President & CEO James B Breitmeyer .
Oncternal Therapeutics Inc (ONCT) Insider Trades Summary
Over the past 18 months, Gunnar F. Kaufmann made no insider transaction in Oncternal Therapeutics Inc (ONCT). Other recent insider transactions involving Oncternal Therapeutics Inc (ONCT) include a net purchase of 9,020 shares made by Robert James Wills , and a net purchase of 980 shares made by David F Hale .
In summary, during the past 3 months, insiders sold 0 shares of Oncternal Therapeutics Inc (ONCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 980 shares of Oncternal Therapeutics Inc (ONCT) were sold and 10,980 shares were bought by its insiders, resulting in a net purchase of 10,000 shares.
Oncternal Therapeutics Inc (ONCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncternal Therapeutics Inc Insider Transactions
Gunnar F. Kaufmann Mailing Address
Above is the net worth, insider trading, and ownership report for Gunnar F. Kaufmann. You might contact Gunnar F. Kaufmann via mailing address: C/o Oncternal Therapeutics, Inc., 12230 El Camino Real, Suite 300, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
